1. Cardiovascular risk reduction in hypertension: angiotensin‐converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?. Issue 3 (March 2016) Authors: Sindone, A.; Erlich, J.; Lee, C.; Newman, H.; Suranyi, M.; Roger, S. D. Journal: Internal medicine journal Issue: Volume 46:Issue 3(2016) Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-11 Plasminogen activator inhibitor 1 enhances venous thrombosis in pancreatic cancer. Issue 200 (April 2021) Authors: Hisada, Y.; Garratt, K.B.; Maqsood, A.; Grover, S.P.; Kawano, T.; Cooley, B.C.; Erlich, J.; Moik, F.; Flick, M.J.; Pabinger, I.; Mackman, N.; Ay, C. Journal: Thrombosis research Issue: Issue 200(2021)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗